Urethral cancer diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
| (7 intermediate revisions by 2 users not shown) | |||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{Vbe}} | {{CMG}}; {{AE}}{{Vbe}} | ||
== Overview == | == Overview == | ||
There is no single diagnostic study of choice for diagnosing urethral cancer. Cystourethroscopy is useful to evaluate the extent of the disease. Definitive diagnosis is made with transurethral biopsies. | There is no single [[diagnostic]] [[Study arms|study]] of choice for [[Diagnosing Heart Failure in the Emergency Department|diagnosing]] [[urethral]] [[cancer]]. Cystourethroscopy is useful to evaluate the extent of the [[disease]]. [[Definitive Surgical Trauma Skills|Definitive]] [[diagnosis]] is made with [[Transurethral needle ablation of the prostate|transurethral]] [[biopsies]]. | ||
== Diagnostic Study of Choice == | == Diagnostic Study of Choice == | ||
=== Study of choice === | === Study of choice === | ||
There is no single [[diagnostic]] study of choice for the [[diagnosis]] of [[urethral]] [[cancer]]; | |||
*Cysto-urethroscopy is done to evaluate the extent of the [[disease]].<ref name="pmid12677777">{{cite journal |vauthors=Guercio S, Terrone C, Scarpa RM |title=[Clinical surveillance after surgery for prostate cancer] |language=Italian |journal=Recenti Prog Med |volume=94 |issue=3 |pages=110–3 |date=March 2003 |pmid=12677777 |doi= |url=}}</ref> | |||
* Retrograde urethrography in [[men]] is used to find the exact location and extent of the [[disease]]. | |||
* | * [[Definitive Surgical Trauma Skills|Definitive]] [[diagnosis]] is made with [[Transurethral needle ablation of the prostate|transurethral]] [[biopsy]]. | ||
* [[CT]] and [[MRI]] is used to evaluate spread of [[cancer]] and to exclude [[metastasis]]. | |||
* | * [[Bone scan]] : Only if there are [[symptoms]] and an elevated level of [[Alkaline phosphatase|Alkaline Phosphatase]]. | ||
* | |||
* | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
Latest revision as of 17:01, 22 January 2019
|
Urethral cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Urethral cancer diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Urethral cancer diagnostic study of choice |
|
Risk calculators and risk factors for Urethral cancer diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Vindhya BellamKonda, M.B.B.S [2]
Overview
There is no single diagnostic study of choice for diagnosing urethral cancer. Cystourethroscopy is useful to evaluate the extent of the disease. Definitive diagnosis is made with transurethral biopsies.
Diagnostic Study of Choice
Study of choice
There is no single diagnostic study of choice for the diagnosis of urethral cancer;
- Cysto-urethroscopy is done to evaluate the extent of the disease.[1]
- Retrograde urethrography in men is used to find the exact location and extent of the disease.
- Definitive diagnosis is made with transurethral biopsy.
- CT and MRI is used to evaluate spread of cancer and to exclude metastasis.
- Bone scan : Only if there are symptoms and an elevated level of Alkaline Phosphatase.